Quick Links
An initiative by leading Biopharmaceutical companies in the world to establish Singapore as the country of choice for global biomedical sciences manufacturing.
News
- All
- BMAC updates
- Press Release
- All
- BMAC updates
- Press Release
Vision Zero Pledge
Site Heads / General Managers / Vice Presidents from 24 Sites across the BMAC Community came together to sign the BMAC Vision Zero Pledge on ...
WSH Care Awards 2025
Three BMAC companies were proud recipients of the WSH CARE Award, a prestigious recognition presented by the Ministry of Manpower (MOM) and the Workplace Safety ...
SERI and Santen collaborate to advance disease-modifying therapies for major eye diseases
The Singapore Eye Research Institute (SERI) and Santen Pharmaceutical Co., Ltd., a global pharmaceutical company committed to eye health headquartered in Osaka, Japan have launched ...
How Singapore is a hub for global biotech and pharmaceutical companies to access growth | Singapore EDB
Global pharma companies are looking to Asia for innovation as they consider what’s next to bolster their pipelines, including sourcing of "Best-in-Class" and "First-in-Class" assets ...
AstraZeneca to hire 800+ for ADC cancer drug facility in Singapore | Singapore EDB
AstraZeneca plans to hire over 800 employees in Singapore for highly skilled roles ranging from engineering, quality, technical services to global supply chain, as it ...
Why the world’s most innovative biotechs are choosing to expand in Asia-Pacific | Singapore EDB
The United States and Europe have traditionally anchored the global biotechnology (biotech) industry, with the combination of robust academic science, ready venture capital, and regulatory ...
Singapore draws international biotech VCs as Asia-Pacific life sciences sector takes off
International biotech venture capital (VC) firms are flocking to Singapore, drawn by the Asia-Pacific region’s growing life sciences sector, with one more European VC confirmed ...
MSD drives smarter sustainability | Singapore EDB
MSD’s Singapore operations are proving that life-saving science can go hand in hand with ambitious climate action. At its manufacturing site here, the global healthcare ...
Novartis Singapore steps up in the race to net-zero | Singapore EDB
Leveraging innovation and a strong culture of sustainability, Novartis Singapore Pharmaceutical Manufacturing (NSPM) aims to cross the significant milestone of carbon neutrality for Scope 1 ...